IFRX - MIC FBIO and CEI among pre market gainers

ChemoCentryx CCXI +71% on FDA approval of Tavneos for treatment of vasculitis (updated) Camber Energy (NYSE:CEI) +33%. eFFECTOR Therapeutics EFTR +22% after-hours on encouraging zotatifin data in breast cancer InflaRx N.V. (NASDAQ:IFRX) +18%. Immuron (NASDAQ:IMRN) +16%. Fortress Biotech (NASDAQ:FBIO) +11% and Cyprium Therapeutics Announce positive clinical data for CUTX-101, copper histidinate, presented at 2021 American academy of pediatrics national conference & exhibition Macquarie Infrastructure (NYSE:MIC) +9%. DatChat (NASDAQ:DATS) +10%. Vaxart VXRT +7% on oral vaccine study showing SARS-CoV-2 transmission reduction in hamsters Brilliant Earth Group (NASDAQ:BRLT) +7%. PEDEVCO (NYSE:PED) +8%. Oatly Group AB (NASDAQ:OTLY) +7%. American Resources (NASDAQ:AREC) +4% expands carbon production with the restart of its McCoy elkhorn complex and secures initial sales contracts Universe Pharmaceuticals (NASDAQ:UPC) +5%.

For further details see:

MIC, FBIO and CEI among pre market gainers